WebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity. Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate WebDec 30, 2024 · Summary DCF Valuation Relative Valuation Wall St Estimates Profitability …
Cytokinin - Wikipedia
WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by … WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... twiddy rentals reviews
Cytokinetics (Nasdaq:CYTK) - Stock Price, News & Analysis
WebJul 19, 2024 · Shares in Cytokinetics surged after it reported positive mid-stage results for CK-274, a drug for hypertrophic cardiomyopathy (HCM) that could tread on the toes of Bristol-Myers Squibb's ... WebValuation Bulls & Bears DCF The closing share price for Cytokinetics (CYTK) stock was … WebApr 7, 2024 · To be assigned a Value Score, stocks must have a valid (non-null) ratio and corresponding ranking for at least two of the six valuation ratios. Stocks with a Value Score from 81-100 are considered deep value, those with a score between 61-80 are value and so on. Cytokinetics, Inc. does not have a meaningful Value Score. twiddy realty outer banks rentals